Department of Medicine, Center for Cardiovascular Research, Center for Lung and Vascular Biology, University of Illinois at Chicago, Chicago, IL 60612, USA.
Hypertension. 2012 Aug;60(2):476-86. doi: 10.1161/HYPERTENSIONAHA.111.189571. Epub 2012 Jul 2.
Extracellular superoxide dismutase (SOD3) is a secretory copper enzyme involved in protecting angiotensin II (Ang II)-induced hypertension. We found previously that Ang II upregulates SOD3 expression and activity as a counterregulatory mechanism; however, underlying mechanisms are unclear. Antioxidant 1 (Atox1) is shown to act as a copper-dependent transcription factor, as well as a copper chaperone, for SOD3 in vitro, but its role in Ang II-induced hypertension in vivo is unknown. Here we show that Ang II infusion increases Atox1 expression, as well as SOD3 expression and activity, in aortas of wild-type mice, which are inhibited in mice lacking Atox1. Accordingly, Ang II increases vascular superoxide production, reduces endothelium-dependent vasodilation, and increases vasoconstriction in mesenteric arteries to a greater extent in Atox1(-/-) than in wild-type mice. This contributes to augmented hypertensive response to Ang II in Atox1(-/-) mice. In cultured vascular smooth muscle cells, Ang II promotes translocation of Atox1 to the nucleus, thereby increasing SOD3 transcription by binding to Atox1-responsive element in the SOD3 promoter. Furthermore, Ang II increases Atox1 binding to the copper exporter ATP7A, which obtains copper from Atox1, as well as translocation of ATP7A to plasma membranes, where it colocalizes with SOD3. As its consequence, Ang II decreases vascular copper levels, which is inhibited in Atox1(-/-) mice. In summary, Atox1 functions to prevent Ang II-induced endothelial dysfunction and hypercontraction in resistant vessels, as well as hypertension, in vivo by reducing extracellular superoxide levels via increasing vascular SOD3 expression and activity.
细胞外超氧化物歧化酶(SOD3)是一种参与保护血管紧张素 II(Ang II)诱导的高血压的分泌型铜酶。我们之前发现,Ang II 通过上调 SOD3 的表达和活性作为一种代偿机制;然而,潜在的机制尚不清楚。抗氧化剂 1(Atox1)在体外被证明是 SOD3 的铜依赖性转录因子和铜伴侣,但它在体内 Ang II 诱导的高血压中的作用尚不清楚。在这里,我们表明 Ang II 输注增加了野生型小鼠主动脉中的 Atox1 表达,以及 SOD3 的表达和活性,而在缺乏 Atox1 的小鼠中则受到抑制。相应地,Ang II 增加了血管内超氧化物的产生,降低了内皮依赖性血管舒张,并增加了肠系膜动脉的血管收缩,在 Atox1(-/-)小鼠中比在野生型小鼠中更为明显。这导致 Atox1(-/-)小鼠对 Ang II 的高血压反应增强。在培养的血管平滑肌细胞中,Ang II 促进 Atox1 向核内易位,从而通过结合 SOD3 启动子中的 Atox1 反应元件增加 SOD3 的转录。此外,Ang II 增加了 Atox1 与铜输出器 ATP7A 的结合,ATP7A 从 Atox1 中获得铜,并将 ATP7A 易位到质膜,在质膜中与 SOD3 共定位。因此,Ang II 降低了血管中的铜水平,在 Atox1(-/-)小鼠中受到抑制。总之,Atox1 通过增加血管 SOD3 的表达和活性来减少细胞外超氧化物水平,从而在体内防止 Ang II 诱导的内皮功能障碍和抗性血管的过度收缩以及高血压。